Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 2896 AL 2910

Genetic Rodent Models of Huntington Disease

Stricker-Shaver J, Novati A, Yu-Taeger L, Nguyen HP.

Adv Exp Med Biol. 2018;1049:29-57. doi: 10.1007/978-3-319-71779-1_2.

Mitochondrial Dysfunction in Huntington's Disease

Carmo C, Naia L, Lopes C, Rego AC.

Adv Exp Med Biol. 2018;1049:59-83. doi: 10.1007/978-3-319-71779-1_3.

RNA Related Pathology in Huntington's Disease

Neueder A, Bates GP.

Adv Exp Med Biol. 2018;1049:85-101. doi: 10.1007/978-3-319-71779-1_4.

Cause or compensation?-Altered neuronal Ca(2+) handling in Huntington's disease

Mackay JP, Nassrallah WB, Raymond LA.

CNS Neurosci Ther. 2018 Apr;24(4):301-310. doi: 10.1111/cns.12817. Epub 2018 Feb 9.

FOXO in Neural Cells and Diseases of the Nervous System

Santo EE, Paik J.

Curr Top Dev Biol. 2018;127:105-118. doi: 10.1016/bs.ctdb.2017.10.002. Epub 2018 Feb 3.

X-Linked Dystonia-Parkinsonism

Evidente VGH.

2005 Dec 13 [updated 2018 Feb 15]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Targeting crosstalk between Nuclear factor (erythroid-derived 2)-like 2 and Nuclear factor kappa beta pathway by Nrf2 activator dimethyl fumarate in epileptogenesis

Singh N, Vijayanti S, Saha L.

Int J Neurosci. 2018 Oct;128(10):987-994. doi: 10.1080/00207454.2018.1441149. Epub 2018 Feb 25.

The antiphospholipid syndrome and its 'non-criteria' manifestations

Joseph FG, Habboush HW.

Pract Neurol. 2018 Apr;18(2):82-83. doi: 10.1136/practneurol-2017-001846. Epub 2018 Feb 15.

Historical perspectives on tardive dyskinesia

Caroff SN, Ungvari GS, Cunningham Owens DG.

J Neurol Sci. 2018 Jun 15;389:4-9. doi: 10.1016/j.jns.2018.02.015. Epub 2018 Feb 3.

Convergent molecular defects underpin diverse neurodegenerative diseases

Tofaris GK, Buckley NJ.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):962-969. doi: 10.1136/jnnp-2017-316988. Epub 2018 Feb 19.

Alteration of GABAergic neurotransmission in Huntington's disease

Garret M, Du Z, Chazalon M, Cho YH, Baufreton J.

CNS Neurosci Ther. 2018 Apr;24(4):292-300. doi: 10.1111/cns.12826. Epub 2018 Feb 21.

Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release

Rebec GV.

CNS Neurosci Ther. 2018 Apr;24(4):281-291. doi: 10.1111/cns.12828. Epub 2018 Feb 21.

Bilateral Striatal Necrosis after Sydenham's Chorea in a 7-Year-Old Boy: A 2-Year Follow-Up

Canavese C, Davico C, Casabianca M, Olivieri C, Mancini S, Migliore G, Versace A, Tocchet A, Vitiello B.

Neuropediatrics. 2018 Jun;49(3):209-212. doi: 10.1055/s-0037-1618590. Epub 2018 Feb 22.

The influence of motor ability rehabilitation on temporal-spatial parameters of gait in Huntington's disease patients on the basis of a three-dimensional motion analysis system: An experimental trial

Mirek E, Filip M, Chwała W, Szymura J, Pasiut S, Banaszkiewicz K, Bar MR, Szczudlik A.

Neurol Neurochir Pol. 2018 Sep-Oct;52(5):575-580. doi: 10.1016/j.pjnns.2018.02.001. Epub 2018 Feb 12.

The Brain-Lung-Thyroid syndrome (BLTS): A novel deletion in chromosome 14q13.2-q21.1 expands the phenotype to humoral immunodeficiency

Villafuerte B, Natera-de-Benito D, González A, Mori MA, Palomares M, Nevado J, García-Miñaur S, Lapunzina P, González-Granado LI, Allende LM, Moreno JC.

Eur J Med Genet. 2018 Jul;61(7):393-398. doi: 10.1016/j.ejmg.2018.02.007. Epub 2018 Feb 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias